Evidence map›Paper›PMID 34156824›Full record

ArticleBioconjugate chemistry2021

Cucurbituril-Ferrocene: Host-Guest Based Pretargeted Positron Emission Tomography in a Xenograft Model.

Vilma I J Jallinoja, Brandon D Carney, Meiying Zhu, Kavita Bhatt, Paul J Yazaki, Jacob L Houghton

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioconjugate chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Pretargeting with Cucurbituril-Adamantane Host-Guest Pair in Xenograft Models.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Vilma I J JallinojaDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.ORCID 0000-0001-5857-6684
Brandon D CarneyDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
Meiying ZhuDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
Kavita BhattDepartment of Radiology, Stony Brook University, Stony Brook, New York 11794, United States.
Paul J YazakiBeckman Institute, City of Hope, Duarte, California 91010, United States.
Jacob L HoughtonDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.ORCID 0000-0003-4255-3044
Stony Brook University · USCity Of Hope National Medical Center · USVanderbilt University Medical Center · US

Funding

Postdoctoral Training in Biomedical MRI and MRST32EB001628 · NIBIB · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John C Gore · 2003 to 2026
$7.0M
Development and Validation of a Robust and Modular Host: Guest-based Pretargeting PlatformR21EB027982 · NIBIB · STATE UNIVERSITY NEW YORK STONY BROOK · PI HOUGHTON, JACOB · 2020 to 2022
$638k
PET System for Preclinical ResearchS10OD016245 · OD · VANDERBILT UNIVERSITY · PI PETERSON, TODD E · 2013 to 2013
$584k
Acquisition of an Applied Biosystems 4000 QTRAP Mass SpectrometerS10RR023680 · NCRR · STATE UNIVERSITY NEW YORK STONY BROOK · PI IDEN, CHARLES R · 2007 to 2007
$435k
NCRR NIH HHS S10 RR023680NIBIB NIH HHS R21 EB027982NIBIB NIH HHS T32 EB001628NIH HHS S10 OD016245
6 · The paper itself

Abstract

Pretargeted positron emission tomography is a macromolecule-driven nuclear medicine technique that involves targeting a preadministered antigen target-bound macromolecule with a radioligand

Indexed as

AnimalsCarcinoembryonic AntigenCucurbit(n)urilsFerrous CompoundsHumansImmunoconjugatesMacrocyclic CompoundsMaleMetallocenesMiceMice, NudePC-3 CellsPositron-Emission TomographyProstatic NeoplasmsRadiopharmaceuticalsCarcinoembryonic AntigenCucurbit(n)urilsferroceneFerrous CompoundsImmunoconjugatesMacrocyclic CompoundsMetallocenesRadiopharmaceuticals

Identifiers

PMID34156824
PMCPMC9153067
OpenAlexW3175219406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.